North America Biosimilars Market (2024-2030) | Analysis, Outlook, Value, Forecast, Growth, Share, Industry, Trends, Companies, Size & Revenue

Market Forecast by Countries (United States, Canada), By Product (Insulin, Follitropin, Calcitonin, Glucagon, Teriparatide, Others), By Indication (Oncology, Offsite Treatment, Chronic Disorders, Blood Disorders, Infectious Diseases, Others), By Manufacturing (Outsourced, In-house) And Competitive Landscape
Product Code: ETC075132 Publication Date: Aug 2021 Updated Date: Jan 2024 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 200 No. of Figures: 90 No. of Tables: 30

Key Highlights of the Report:

  • North America Biosimilars Market Outlook
  • Market Size of North America Biosimilars Market, 2020
  • Forecast of North America Biosimilars Market, 2030
  • Historical Data and Forecast of North America Biosimilars Revenues & Volume for the Period 2020 - 2030
  • North America Biosimilars Market Trend Evolution
  • North America Biosimilars Market Drivers and Challenges
  • North America Biosimilars Price Trends
  • North America Biosimilars Porter's Five Forces
  • North America Biosimilars Industry Life Cycle
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of North America Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of United States Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of Canada Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • North America Biosimilars Market - Key Performance Indicators
  • North America Biosimilars Market - Import Export Trade Statistics
  • North America Biosimilars Market - Opportunity Assessment By Countries
  • North America Biosimilars Market - Opportunity Assessment By Product
  • North America Biosimilars Market - Opportunity Assessment By Indication
  • North America Biosimilars Market - Opportunity Assessment By Manufacturing
  • North America Biosimilars Market - Top Companies Market Share
  • North America Biosimilars Market - Top Companies Profiles
  • North America Biosimilars Market - Comparison of Players in Technical and Operating Parameters
  • North America Biosimilars Market - Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 North America Biosimilars Market Overview

3.1 North America Regional Macro Economic Indicators

3.2 North America Biosimilars Market Revenues & Volume, 2020 & 2030F

3.3 North America Biosimilars Market - Industry Life Cycle

3.4 North America Biosimilars Market - Porter's Five Forces

3.5 North America Biosimilars Market Revenues & Volume Share, By Countries, 2020 & 2030F

3.6 North America Biosimilars Market Revenues & Volume Share, By Form, 2020 & 2030F

3.7 North America Biosimilars Market Revenues & Volume Share, By Indication, 2020 & 2030F

3.8 North America Biosimilars Market Revenues & Volume Share, By Manufacturing, 2020 & 2030F

4 North America Biosimilars Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 North America Biosimilars Market Trends

6 North America Biosimilars Market, 2020 - 2030

6.1 North America Biosimilars Market, Revenues & Volume, By Product, 2020 - 2030

6.2 North America Biosimilars Market, Revenues & Volume, By Indication, 2020 - 2030

6.3 North America Biosimilars Market, Revenues & Volume, By Manufacturing, 2020 - 2030

7 United States Biosimilars Market, 2020 - 2030

7.1 United States Biosimilars Market, Revenues & Volume, By Product, 2020 - 2030

7.2 United States Biosimilars Market, Revenues & Volume, By Indication, 2020 - 2030

7.3 United States Biosimilars Market, Revenues & Volume, By Manufacturing, 2020 - 2030

8 Canada Biosimilars Market, 2020 - 2030

8.1 Canada Biosimilars Market, Revenues & Volume, By Product, 2020 - 2030

8.2 Canada Biosimilars Market, Revenues & Volume, By Indication, 2020 - 2030

8.3 Canada Biosimilars Market, Revenues & Volume, By Manufacturing, 2020 - 2030

9 North America Biosimilars Market Key Performance Indicators

10 North America Biosimilars Market - Opportunity Assessment

10.1 North America Biosimilars Market Opportunity Assessment, By Countries, 2020 & 2030F

10.2 North America Biosimilars Market Opportunity Assessment, By Product, 2020 & 2030F

10.3 North America Biosimilars Market Opportunity Assessment, By Indication, 2020 & 2030F

10.4 North America Biosimilars Market Opportunity Assessment, By Manufacturing, 2020 & 2030F

11 North America Biosimilars Market - Competitive Landscape

11.1 North America Biosimilars Market Revenue Share, By Companies, 2020

11.2 North America Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters

12 Company Profiles

13 Recommendations

14 Disclaimer

Pricing
  • Single User License
    $ 4,560
  • Department License
    $ 5,055
  • Site License
    $ 5,595
  • Global License
    $ 6,000
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All